News & Media: All

Feb 20, 2017

"Value of Hope" Study of Patient and Physician Preferences Published in Value in Health

The "Value of Hope" study, examining patient and physician preferences for durable survival, was recently published in a special issue of Value in Health-- focusing on value assessment frameworks.

To read the complete study by PHE authors Jason Shafrin, Taylor Schwartz, John Romley, et al, plea ...

Feb 10, 2017

Shafrin in eyeforpharma: Value-based Pricing’s Time Has Come, and It’s Here to Stay

In "The Price of Everything and the Value of Nothing," PHE Senior Research Economist Jason Shafrin talks prices, politics, and the problem of monopolies with eyeforpharma’s Hugh Gosling.

To read the complete article, please click here.

Feb 9, 2017

Precision To Have Prominent Presence at AMCP Annual Meeting 2017

AMCP is coming to Denver March 27th -30th, and Precision is looking forward to the chance to show off our capabilities and experts with a booth presence, two presentations, four posters and more!

Look for us on the exhibitor floor in Booth 312, and check below for complete information on all of ...

Feb 2, 2017

Neumann Discusses Cures Act and New FDA Draft Guidance on Communication

In his latest Health Affairs blog posting, PHE Scientific Advisor Peter Neumann and co-author Elle Pope examine Section 3037 of the Cures Act and new FDA draft guidance, which indicate that drug companies will have expanded flexibility to communicate proactively with payors and formulary committ ...

Jan 31, 2017

PHE Team Author New Study on Medicare Part D Price Controls

In "The Long-Term Impact of Price Controls in Medicare Part D," a new scientific paper recently published in Forum for Health Economics and Policy, PHE authors Gigi Moreno, Emma van Eijdnhoven, Jennifer Benner and Jeffrey Sullivan examine the potential impact over time of government price settin ...

Jan 19, 2017

PHE's Thorlund Named to List of Top 1% Most Cited Researchers in the World

Precision Health Economics is proud to congratulate Kristian Thorlund, Vice President, Health Analytics, for being named by Clarivate Analytics to their list of "Highly Cited Researchers," representing the top 1% of the most cited researchers in the world. The list is based on the Essential Scie ...

Jan 19, 2017

Peter Neumann in New England Journal of Medicine: Cost-Effectiveness 2.0 -- Poised for a Second Act?

PHE Scientific Advisor Peter Neumann, along with co-author Gillian Sanders, offers a new perspective on cost-effectiveness analysis, just published in the New England Journal of Medicine. Neumann and Sanders provide an overview of recent work, and argue that cost-effectiveness analysis should be ...

Jan 9, 2017

Philipson in Forbes: Is Disneyland the Future of Personalized Medicine?

In Tomas Philipson's latest commentary, he wonders whether the pricing system used by Disneyland and other amusement parks is a concept applicable to personalized medicine.

To read the complete commentary, please click here.

Jan 5, 2017

Jason Shafrin's Blog Named One of the Top 100 Economics Blogs of 2016

Precision Health Economics Senior Research Economist Jason Shafrin's blog, "Healthcare Economist," has been named as one of the top 100 economics blogs of 2016 by Intelligent Economist. The editors write: "His blog is filled with unbiased and research driven critiques of today’s healthcare is ...

Jan 4, 2017

PHE's Anupam Jena Named One of the 60 Most Powerful People in Healthcare for 2016

Precision Health Economics is proud to announce that Scientific Advisor Anupam Jena, MD has been named by Becker's Hospital Review as one of the 60 most powerful people in healthcare in 2016, joining other influential leaders such as Robert Califf, Frances Collins, David Feinberg, Bill & Melinda ...

Jan 3, 2017

Jason Shafrin Interviewed in The Journal of Healthcare Contracting

PHE Senior Research Economist Jason Shafrin discusses the need for and mission of the Innovation and Value Initiative, as well as the keys to its success in the latest edition of The Journal of Healthcare Contracting. "If we find a research topic that life sciences, payers, providers are all beh ...

Dec 12, 2016

Linthicum and Shafrin Discuss the Science of Value Assessment in GEN News

PHE's Mark Linthicum and Jason Shafrin discuss advancing the science of value assessment and the mission of the Innovation and Value Initiative in the latest edition of Genetic Engineering and Biotechnology News.

To read the complete article, please click here.

Dec 9, 2016

Jason Shafrin in The Washington Post: How We Should Pay for Cures

PHE Senior Research Economist Jason Shafrin's latest Op-ed is featured in The Washington Post, as part of their "In Theory" series. The commentary, "How we should pay for cures, according to economics," examines the current complexities of drug pricing and advocates for value-based pricing struc ...

Dec 8, 2016

Precision's Jena Featured on Freakonomics Podcast

PHE Scientific Advisor Anupam Jena was recently featured on the award-winning podcast Freakonomics, as part of their "Bad Medicine: The Story of 98.6" 3-part series. Episode one addresses some of the historical mistakes produced by "trial and error" medicine, and asks whether the new era of evid ...

Dec 5, 2016

Philipson in Forbes: Assessing Healthcare Value Needs a Decentralized Approach

In Tomas Philipson's latest commentary, he provides a step-by-step breakdown of the steps necessary for creating a new, decentralized and scientific approach to value assessment.

To read the complete editorial, please click here.

Nov 22, 2016

Jason Shafrin in MedCity News: "Precision Medicine Will Increase Drug Prices and That's A Good Thing"

PHE Senior Research Economist Jason Shafrin details the benefits and challenges of precision medicine in a new commentary for MedCity News.

To read the complete article, please click here.

Nov 15, 2016

Precision's Shih Addresses 'Peace of Mind' Value in Multiple Sclerosis News Today

PHE Research Economist Tiffany Shih's recent study, "Reconsidering the Economic Value of Multiple Sclerosis Therapies," as published in the American Journal of Managed Care, examines "peace of mind" value represented by novel MS therapies.

Click here to read a discussion of the study, includin ...

Nov 11, 2016

Lakdawalla and Goldman in STAT News: Pharma Needs a New Prescription

Precision Health Economics founders Darius Lakdawalla and Dana Goldman contribute a new commentary for STAT News: "Election Verdict: Pharma Needs a New Prescription."

To read the complete commentary, please click here.

Nov 4, 2016

Philipson and Lakdawalla in Forbes: Rethinking FDA Approval Framework

Tomas Philipson and Darius Lakdawalla address the FDA approval framework in their latest commentary for Forbes.

For the complete article, please click here.

Nov 4, 2016

PHE's Ward, Linthicum and Silverstein in Health Affairs: Examining Barriers to Value-Based Agreements

In a new blog on the Health Affairs website, PHE's Alison Sexton Ward, Mark Linthicum and Alison Silverstein examine the regulatory and legal uncertainties existing as barriers to value-based agreements for drugs.

To read the complete blog, please click here.

Oct 31, 2016

Shafrin Discusses Obamacare on NPR's 'Here and Now'

PHE's senior research economist Jason Shafrin discusses anticipated premium price surges and the future for Obamacare on NPR's "Here and Now."

For the complete audio interview, please click here.

Oct 28, 2016

Multiple PHE Authors Featured in Latest Edition of JMCP

We are proud to announce that multiple studies by PHE authors are featured in the latest edition of the JMCP.

Readers will find "Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia," by PHE authors Ja ...